SK Bioscience Co Ltd banner

SK Bioscience Co Ltd
KRX:302440

Watchlist Manager
SK Bioscience Co Ltd Logo
SK Bioscience Co Ltd
KRX:302440
Watchlist
Price: 43 750 KRW -1.13% Market Closed
Market Cap: ₩3.4T

Wall Street
Price Targets

Price Targets Summary
SK Bioscience Co Ltd

Wall Street analysts forecast SK Bioscience Co Ltd stock price to drop over the next 12 months.

According to Wall Street analysts, the average 1-year price target for SK Bioscience Co Ltd is 38 505 KRW with a low forecast of 25 250 KRW and a high forecast of 52 500 KRW.

Lowest
Price Target
25 250 KRW
42% Downside
Average
Price Target
38 505 KRW
12% Downside
Highest
Price Target
52 500 KRW
20% Upside
SK Bioscience Co Ltd Competitors:
Price Targets
MASI
Masimo Corp
3% Upside

Revenue
Forecast

8% / Year
Past Growth
21% / Year
Estimated Growth
Estimates Accuracy
0%
Average Miss
8% / Year
Past Growth
21% / Year
Estimated Growth
Estimates Accuracy
0%
Average Miss

For the last 5 years the compound annual growth rate for SK Bioscience Co Ltd's revenue is 8%. The projected CAGR for the next 4 years is 21%.

Operating Income
Forecast

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-16%
Average Miss
N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-16%
Average Miss

Net Income
Forecast

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-12%
Average Miss
N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-12%
Average Miss
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is SK Bioscience Co Ltd's stock price target?
Price Target
38 505 KRW

According to Wall Street analysts, the average 1-year price target for SK Bioscience Co Ltd is 38 505 KRW with a low forecast of 25 250 KRW and a high forecast of 52 500 KRW.

What is SK Bioscience Co Ltd's Revenue forecast?
Projected CAGR
21%

For the last 5 years the compound annual growth rate for SK Bioscience Co Ltd's revenue is 8%. The projected CAGR for the next 4 years is 21%.

Back to Top
Get AI-powered insights for any company or topic.
Open AI Assistant

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett